Morgens Waterfall Vintiadis & CO Inc Astrazeneca PLC Transaction History

Morgens Waterfall Vintiadis & CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $2.37 Million - $2.95 Million	-49,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $235,799 - $272,200	-5,000 Reduced 9.26%	49,000 $2.44 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $1.84 Million - $2.37 Million	42,800 Added 382.14%	54,000 $2.86 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $64,243 - $87,261	-1,700 Reduced 13.18%	11,200 $500,000
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $25,802 - $29,043	700 Added 5.74%	12,900 $490,000
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $402,234 - $446,886	12,200 New	12,200 $427,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Morgens Waterfall Vintiadis & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Morgens Waterfall Vintiadis & CO Inc with notifications on news.